Impact of Tadalafil Once Daily in Men With Erectile Dysfunction—Including a Report of the Partners' Evaluation
To access this article, please choose from the options below
This work was supported by Lilly, United States, LLC, including assistance with manuscript preparation provided by Danette Hann, PhD (i3 Statprobe).
Dr. Althof is consultant or adviser for Pfizer, Palitan, GSK, Eli Lilly, Boehringer-Ingelheim, Johnson and Johnson, Plethora and a Principal Investigator for Boehringer-Ingelheim and Plethora.
Dr. Rubio-Aurioles is currently a consultant, investigator and speaker for Eli Lilly, Bayer Schering, Boehringer-Ingelheim, and More Pharma, Mexico.
Dr. Kingsberg is an investigator for BioSante, Procter & Gamble, Boehringer-Ingelheim, a consultant for Wyeth and Boehringer-Ingelheim, on the speakers bureau for Eli Lilly, and has received honoraria from Johnson & Johnson.
Mrs. Zeigler is an employee of Lilly USA, LLC.
Dr. Wong and Dr. Burns are employees of Lilly, United States, LLC and own stock in the company.
PII: S0090-4295(09)03108-2
doi:10.1016/j.urology.2009.11.066
© 2010 Elsevier Inc. All rights reserved.
